Astrana Health Inc

Healthcare · Medical Care Facilities

36.40$ +5.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Astrana Health Inc (ASTH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 973 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ASTH
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	15	16	15	42	40	260	124	123	167	105	96	130	156	179	165	165	180	177	176	176	227	195	263	270	317	294	337	348	348	353	404	486	479	665	620	655	956	951	965	973	3,844
Cost of Revenue	12	13	14	40	39	180	85	99	97	79	83	101	131	152	144	136	122	137	141	136	147	172	221	230	241	253	289	293	275	314	335	420	405	602	549	577	874	872	875	868	3,490
Gross Profit	2.5	3.0	1.0	1.3	1.4	79	39	24	70	26	12	29	25	27	21	29	58	40	35	39	80	23	43	40	76	41	48	55	73	39	69	66	73	63	71	78	82	79	90	104	355
Research & Development	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Administrative	4.5	4.5	5.8	4.9	5.3	10	12	11	9.0	12	10	12	8.0	11	12	12	16	9.5	9.5	14	22	17	12	20	21	24	21	24	29	38	39	36	38	42	44	51	113	9.5	62	54	239
Total Operating Expenses	4.6	4.6	6.0	5.0	5.5	31	17	16	14	20	16	14	13	16	17	16	21	14	14	18	26	21	16	24	26	29	25	28	34	43	39	36	45	62	51	58	62	60	62	70	254
Operating Income	-2.2	-1.7	-4.9	-3.7	-4.1	49	23	7.1	57	2.0	-3.3	15	10	11	4.4	13	37	26	22	21	53	2.2	26	15	50	13	22	27	39	-3.9	30	30	28	0.7	21	20	19	18	29	34	100
Interest Expense	0.0	0.0	0.1	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.8	3.4	2.9	2.7	2.5	1.5	1.5	1.9	1.0	1.1	1.1	1.9	2.4	2.6	3.3	3.6	3.8	5.4	7.6	8.6	8.9	8.1	7.3	7.4	18	18	16	16	67
Pre-Tax Income	-1.7	-1.4	-4.7	-3.9	-4.3	63	23	9.4	53	-2.9	-3.9	15	14	0.4	4.6	113	36	25	21	84	-5.5	-22	18	17	41	10	19	31	38	0.9	24	32	27	-1.9	9.6	17	5.7	7.5	20	27	60
Income Tax Expense	-0.2	0.1	0.1	0.0	0.0	14	7.2	1.5	15	-1.0	-1.4	4.2	3.7	1.7	1.6	32	11	12	6.8	25	-0.1	-3.1	6.8	5.4	17	10.0	6.9	14	10	1.0	7.1	10	7.8	5.9	3.4	6.6	4.6	0.9	6.6	8.8	21
Net Income	-1.4	-1.7	-4.6	-3.6	-3.9	38	2.2	2.7	9.1	-3.1	0.1	3.5	3.7	6.7	4.1	7.0	17	10	13	13	34	14	14	12	23	-2.6	13	13	22	12	15	19	16	-7.0	6.7	9.4	0.4	6.0	14	20	41
EBITDA	-2.0	-1.5	-4.8	-3.5	-3.9	67	28	14	58	1.7	0.8	20	22	8.7	12	21	43	30	27	91	0.1	-17	24	23	48	17	27	39	46	11	37	48	43	14	24	31	39	41	51	43	175

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings